Search
-
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies
(Lancet HIV. vol. 11, n° 2, pp. e106-e116, 2024-01-12)Article de revue -
CRP under 130 mg/L rules out the diagnosis of Legionella pneumophila serogroup 1 (URINELLA Study)
(European Journal of Clinical Microbiology & Infectious Diseases, 2024-03-26)Article de revueOpen access -
Evaluating the Use of Generalized Dynamic Weighted Ordinary Least Squares for Individualized Hiv Treatment Strategies
(Annals of Applied Statistics. vol. 17, n° 3, pp. 2432-2451, 2023-09)Article de revueOpen access -
Post-clustering difference testing: valid inference and practical considerations
(Computational Statistics and Data Analysis)Article de revueOpen access -
Statistical classification of treatment responses in mouse clinical trials for stratified medicine in oncology drug discovery
(Scientific Reports. vol. 14, n° 1, pp. 934, 2024-01-09)Article de revueOpen access -
Time to treatment initiation and HIV viral suppression in people diagnosed with HIV-1 during COVID-19 pandemic in ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study)
(Journal of Acquired Immune Deficiency Syndromes - JAIDS, 2023-09-28)Article de revue -
Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration
(The Lancet HIV. vol. 10, n° 11, pp. e723-e732, 2023-11)Article de revue -
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
(Lancet Global Health. vol. 11, n° 11, pp. e1743-e1752, 2023-11)Article de revueOpen access -
A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease
(Cell Reports Medicine. vol. 5, n° 3, pp. 101467, 2024-03-19)Article de revueOpen access -
T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial
(Journal of Immunology. vol. 208, n° 12, pp. 2663-2674, 2022-06-15)Article de revue